You are currently viewing a new version of our website. To view the old version click .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 15, Issue 2

April 2008 - 11 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (11)

  • Guidelines
  • Open Access
9 Citations
193 Views

Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline

  • S. Verma,
  • T. Petrella,
  • C. Hamm,
  • K. Bak,
  • M. Charette and
  • the members of the Melanoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care

1 April 2008

Questions: 1. What is the role of biochemotherapy in the treatment of metastatic malignant melanoma? 2. What are the adverse effects and effects on quality of life of biochemotherapy as a treatment option? For the purposes of this report, “biochemoth...

  • Article
  • Open Access
46 Citations
1,325 Views
4 Pages

1 April 2008

Methylation of DNA is known to be an important mechanism of gene regulation. A hallmark of cancer is the deregulation of the DNA methylation machinery and aberrant DNA methylation patterns 1. In vertebrate genomes, a large fraction of the CG dinucleo...

  • Article
  • Open Access
13 Citations
848 Views
1 Page

Traditional Chinese Medicine (TCM) is a whole system containing therapeutic interventions that individually induce biomodulation at the physiologic, chemical, and molecular levels. The theory of TCM proposes a synergy between specific interventions s...

  • Article
  • Open Access
6 Citations
769 Views
5 Pages

1 April 2008

Questions: (1) In patients with inoperable locally advanced or metastatic soft tissue sarcoma, does first-line doseintensive chemotherapy supported by growth factor or autologous bone marrow or stem-cell transplantation improve response rate, time to...

  • Article
  • Open Access
11 Citations
931 Views
8 Pages

An Approach to the Management of Chronic Myeloid Leukemia in British Columbia

  • D. L. Forrest,
  • X. Jiang,
  • C. J. Eaves and
  • C. L. Smith

1 April 2008

Chronic myeloid leukemia (CML) is a myeloproliferative disorder whose therapy has changed dramatically since the late 1990s. With the introduction of the tyrosine kinase inhibitor (TKI) imatinib mesylate, the treatment outcomes for patients with CML...

  • Article
  • Open Access
6 Citations
803 Views
6 Pages

Predictors of Positive Radial Margin Status in a Population-Based Cohort of Patients with Rectal Cancer

  • P.T. Phang,
  • H. Kennecke,
  • C.E. McGahan,
  • J. MacFarlane,
  • G. McGregor and
  • J.H. Hay

1 April 2008

Background: Surgical margin status is an important predictor of risk of relapse among patients with rectal cancer. Methods: Patients referred to the British Columbia Cancer Agency for consideration of adjuvant therapy for rectal adenocarcinoma were i...

  • Article
  • Open Access
2 Citations
698 Views
8 Pages

Malignant Mesothelioma: Canadian Perspective and Research Directions

  • C.W. Lee,
  • J. Martin,
  • R. MacRae,
  • M.S. Tsao,
  • E. Nguyen,
  • M. Johnston,
  • P. Baas,
  • S. Laurie,
  • R. Feld and
  • N. Murray
  • + 1 author

1 April 2008

Since the 1960s, the incidence of malignant mesothelioma in Canada has increased dramatically because of work-related asbestos exposures. Treatment options are limited. Although chemotherapy is now an accepted standard in the management of advanced d...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729